KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $52.6 million.

  • Dynavax Technologies' Share-based Compensation fell 5.30% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.8 million, marking a year-over-year increase of 3.74%. This contributed to the annual value of $52.6 million for FY2024, which is 23.54% up from last year.
  • Dynavax Technologies' Share-based Compensation amounted to $52.6 million in FY2024, which was up 23.54% from $42.6 million recorded in FY2023.
  • Dynavax Technologies' 5-year Share-based Compensation high stood at $52.6 million for FY2024, and its period low was $13.5 million during FY2020.
  • For the 3-year period, Dynavax Technologies' Share-based Compensation averaged around $42.7 million, with its median value being $42.6 million (2023).
  • Per our database at Business Quant, Dynavax Technologies' Share-based Compensation tumbled by 47.03% in 2020 and then skyrocketed by 57.85% in 2021.
  • Over the past 5 years, Dynavax Technologies' Share-based Compensation (Yearly) stood at $13.5 million in 2020, then skyrocketed by 57.85% to $21.3 million in 2021, then skyrocketed by 54.64% to $32.9 million in 2022, then grew by 29.40% to $42.6 million in 2023, then climbed by 23.54% to $52.6 million in 2024.